Barclays analyst Benjamin Theurer downgraded FMC (FMC) to Equal Weight from Overweight with a price target of $22, down from $48, following the earnings report. The firm sees no reason to be positive on the shares given the “soft” results, FMC’s “limited to no visibility” on earnings in coming quarters and a “surprise cut” of its dividend.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC: